Protection from H1N1 (Swine Flu)
[Announcer] This podcast is presented by the Centers for Disease Control and Prevention. CDC – safer, healthier people.
Welcome to Ask CDC, the weekly podcast that answers your questions. I'm your host, Susan Laird.
We've received a lot of questions related to the swine flu outbreak, which is really called H1N1 flu. The question we'll answer today is what can I do to protect myself and my family from H1N1?
H1N1 infection can cause a wide range of symptoms, including fever, cough, sore throat, body aches, headache, chills, and fatigue. People with H1N1 flu can also have diarrhea and vomiting. Like seasonal flu, H1N1 flu in humans can vary from mild to severe. Severe disease with pneumonia or respiratory failure and even death is possible with H1N1 influenza infection.
Antiviral drugs, prescription medicines that fight against the flu by keeping flu viruses from reproducing in the body, can treat or prevent infection in high-risk individuals. Certain groups might be more likely to develop a severe illness from H1N1 influenza infection, such as persons with chronic medical conditions, and when a high-risk individual gets flu or is exposed to flu, antiviral drugs are often recommended. They are also recommended for some persons who have been in contact with people diagnosed with H1N1 influenza. Antiviral drugs may also be used to treat people who have been infected. These drugs can make the illness milder and make infected people feel better faster.
The main way that influenza viruses are thought to spread from person-to-person is in respiratory droplets of coughs and sneezes. This can happen when droplets from a cough or sneeze of an infected person are propelled through the air and deposited on the mouth or nose of people nearby. Influenza viruses may also be spread when a person touches respiratory droplets on another person or an object and then touches their own mouth or nose, or someone else's mouth or nose, before washing their hands.
There are basic things people can do every day to reduce their risk for getting any infectious disease, including H1N1 influenza. Teach your children and share the information with friends and family.
• Wash your hands often with soap and water, especially after you cough or sneeze. Use an alcohol-based hand cleaner if soap and water aren't available.
• Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
• Avoid touching your eyes, nose, or mouth. That's how germs spread.
And
• Help stop the spread of the virus. If you or your children are sick – don't go to work or send your children to school.
For up-to-date information on H1N1 influenza, please visit www.cdc.gov or call 1-800-CDC-INFO or 1-800-232-4636.
Thanks for listening. To submit your question to Ask CDC, email us at askcdc@cdc.gov.
[Announcer] For the most accurate health information, visit www.cdc.gov or call 1-800-CDC-INFO, 24/7.
Predicting Heart Attack Risk
Proyecto Jupiter Proteina C Reactiva (Inglés)
Evaluating Stroke Biomarkers (Inglés)
Información CDC Gripe Porcina
Reconocimiento a Raquel Osatinsky
Marcadores de estrés oxidativo: ¿Teoría o práctica? 1º parte
Marcadores de estrés oxidativo: ¿Teoría o práctica? 2º parte
Acto de reconocimiento a profesionales
Acto Inaugural. Apertura. Reconocimiento a la Dra. Raquel Osatinsky
Médicos y bioquímicos en busca de consenso para un valor estimado del filtrado glomerular. Su importancia en la atención primaria - 1º Parte
Médicos y bioquímicos en busca de consenso para un valor estimado del filtrado glomerular. Su importancia en la atención primaria - 2º Parte
Nefrotoxicidad de las crioglobulinas. • Asociación entre hepatitis C y producción de crioglobulinas (1º parte)
Asociación entre hepatitis C y producción de crioglobulinas (2º parte) .• Laboratorio clínico en el estudio de las crioglobulinemias (1º parte).
The Ubiquitin Proteolytic System: From Basic Mechanisms through Human Diseases and onto Drug Targeting. (1º parte) (Inglés)
Understanding the T helper response against HIV and CD4+ T-cell-inducing HIV vaccines. (Inglés)
The Ubiquitin Proteolytic System: From Basic Mechanisms through Human Diseases and onto Drug Targeting. (2º parte) (Inglés)
What is EBLM and how to apply it. (Inglés)
Screening and EBLM: is there a sufficient case for PSA testing? (Inglés)
EBM in cardiac medicine. A case based approach.
Presentación disertantes (10 min) - Biological markers to asses glycaemic control in Diabetes Mellitus (1º parte) (Inglés)
Biological markers to asses glycaemic control in Diabetes Mellitus (2º parte) (Inglés)
Post-translational modifications of proteins in Diabetes (Inglés)
Diabetes and prediabetes: Laboratory update and new diagnostic perspectives (1º parte) (Inglés)
Diabetes and prediabetes: Laboratory update and new diagnostic perspectives (2º parte) (Inglés)
Gene-environment interactions in cardiovascular diseases (1º parte) (Inglés)
Gene-environment interactions in cardiovascular diseases (2º parte) (Inglés)
The clinical application of serum proteomic profile in elderly population (1º parte) (Inglés)
The clinical application of serum proteomic profile in elderly population (2º parte) (Inglés)
Frequency of anemia in elderly population attending for LEPACUEM in 2007 (Inglés)
Metabolic syndrome as risk factor to severe oxidative stress in elderly (Inglés)
Epigenic and genetic profiling in colorectal cancer (Inglés)
SNP analysis and DNA Sequencing based on Molecular Charges.(1º parte) (Inglés)
SNP analysis and DNA Sequencing based on Molecular Charges. (2º parte) (Inglés)
Molecular diagnostic testing in oncology: Clinical utility of mutation detection in cancer prognosis and treatment prediction. (1º parte) (Inglés)
Molecular diagnostic testing in oncology: Clinical utility of mutation detection in cancer prognosis and treatment prediction. (2º parte) (Inglés)
Association between capn10 gene polymorphism and polycystic ovary syndrome in southern chilean women. (Inglés)
Progress in molecular diagnostics of syndromic Hirschsprung diseases and other neurocristopathies. (Inglés)
Laboratory assessment of nutritional status – Where is the evidence? (1º parte) (Inglés)
Laboratory assessment of nutritional status – Where is the evidence? (2º parte) (Inglés)
Obesity laboratory-from bench to bedside. (1º parte) (Inglés)
Obesity laboratory-from bench to bedside. (2º parte) (Inglés)
Detection and possible physiological significance of a CEHC, an urinary metabolite of vitamin E. (Inglés)
Impact of the nutritional status on paf-ah activity and cardiovascular risk biomarkers in adolescents. (Inglés)
Plasma protein biomarker discovery and the peptide atlas. (Inglés)
Understanding the Human proteome. (Inglés)
A Human protein atlas.(Inglés)
Proteomics and clinical chemistry. (Inglés)
Phosphorilation predictors application as analytical model to the muscular condition. (Inglés)
Fully automated multi-analytical measurement of circulating cytokines and cytokine related markers on evidence biochip arrays. (Inglés)
New developments in allergy diagnostics: From IgE to cellular testing. (Inglés)
Diagnostic value of screening and differential testing for antinuclear antibodies. (Inglés)
Chemokine and Chemokine receptors: New inflammatory markers on the horizon. (Inglés)
Inverse relationship between paraoxonase level and symptoms of asthma.(Inglés)
Biochemical markers on bone turnovers Diagnostics for Clinical practice. (Inglés)
Assessment of bone turnover marker plots. (1º parte) (Inglés)
Assessment of bone turnover marker plots. (2º parte) Inglés)
Osteoprogeterim and receptor activator of NF-KB, Novel biomarkers of bone remodeling. (Inglés)
Evaluation of the direct immunoassay eclia 25-OH-D3-Vitamin on Roche Modular E 170-Analizer. (Inglés)
Hormonal contraceptives, bone turnover and risk of osteoporosis. (Inglés)
The effect of partial hepactomy on bone metabolism in rats. (Inglés)
From la bon a chip to a lab-in-a cell. (Inglés)
High throughput single cell cultivation and analysis platform. (Inglés)
Emerging markers on acute coronary syndrome: beyond the troponins. (Inglés)
The value of markers in nonischemic heart diseases. (Inglés)
Detection of transient myocardical ischemia using a highly sensitive, single molecule, troponine I assay. (1º parte) (Inglés)
Detection of transient myocardical ischemia using a highly sensitive, single molecule, troponine I assay. (2º parte) (Inglés)
Impact of assay related issues in B-type natriuretic peptide quantification. (Inglés)
Clinical applications of B-type natriuretic peptide testing. (Inglés)
Pentraxina-3 levels ion patients with coronary artery disease in a sample of Brazilian population. (Inglés)
Pharmacogenetics testing for warfarin anticoagulation. (Inglés)
Germline pharmacogenomics in the treatment of breast cancer. (Inglés)
Pharmacogenetics in psychiatry: an update. (Inglés)
Pharmacogenetics in transplantation medicine. (Inglés)
Metabolic abnormalities among female patients with squizophrenia following traetment with second generation antipsychotic are associated with abcb1 genetic polimorphisms. (Inglés)
Molecular methodes applied to Hepatitis C diagnosis and monitoring. (1º parte) (Inglés)
Molecular methodes applied to Hepatitis C diagnosis and monitoring. (2º parte) (Inglés)
Innovation on the molecular diagnosis of leishmaniosis. (Inglés)
Mutation of toll-like receptor 2 in a lepromatous leprosy patient. (Inglés)
Technological developments in mass spectrometry towards multiplexing and high throughput analysis. (1º parte) (Inglés)
Technological developments in mass spectrometry towards multiplexing and high throughput analysis. (2º parte) (Inglés)
Rise of mass spectrometry-fall of immunoassay? Point of view of an immunoassay manufacturer. (Inglés)
Rise of mass spectrometry-fall of immunoassay? Point of view of an immunoassay manufacturer. (Inglés)
Rise of mass spectrometry-fall of immunoassay? Point of view of the clinical laboratory. (Inglés)
Measurement of 25-hydroxyl vitamin D in blood by liquid chromatography tandem mass spectrometry and comparison to a radioimmunoassay method. (Inglés)
Determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry. (Inglés)
Strategic and financial planning: Critical for the clinical laboratory. (Inglés)
Staffing and privatization of clinical laboratories: two challenges for the next decade. (1º parte) (Inglés)
Staffing and privatization of clinical laboratories: two challenges for the next decade. (2º parte) (Inglés)
Minimizing errors from test ordering to result reporting. (Inglés)
Integrated pathways: the role of the clinical laboratory. (Inglés)
Patterns of thyroid disorders among the neplase patients attending referral health care centre. (Inglés)
Reflective testing: podsitive effect on patient management as judged by general practitioners. (Inglés)
Instructivo uso de Barbijos
Instructivo lavado de manos
H1N1 Influenza (Gripe porcina)
Gripe H1N1 y Drogas Antivirales
H1N1 - Creando un lugar de trabajo seguro y saludable (Inglés)
Laboratorio clínico en el estudio de las crioglobulinemias. 2º parte
Información para niños: Lo que puedes hacer para que no te dé influenza (Español)